Skip to main content

CDC Licenses Golden Helix's Genome Association Software for Blood Disorder Research

NEW YORK (GenomeWeb News) – The US Centers for Disease Control and Prevention has expanded a license agreement with Golden Helix for the company’s genetic association software platforms for use in whole-genome association studies, the company said today.
 
The CDC will use the Golden Helix SNP and Variation Suite, including the HelixTree software for population-based studies, the PBAT software for family-based studies, and the CNAM copy number association tool.
 
This agreement marks the first time that the CDC has licensed the Golden Helix software for use in its Division of Blood Disorders, the company added.
 
Financial terms of the agreement were not released.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.